HIV/AIDS

FDA approves antiretroviral therapy for multidrug-resistant HIV

FDA approves antiretroviral therapy for multidrug-resistant HIV

By

The FDA has approved Trogarzo for heavily treated adult patients living with HIV and whose HIV infections cannot be successfully treated with other currently available therapies.

CVS unintentionally reveals HIV status of 6,000 customers, per lawsuit

CVS unintentionally reveals HIV status of 6,000 customers, per lawsuit

By

CVS Health faces lawsuit for revealing the HIV status of 6,000 patients in Ohio.

Fatigue, muscle aches more common in women with HIV than men

Fatigue, muscle aches more common in women with HIV than men

The two most prevalent HIV symptoms, fatigue and muscle aches, are more common in women than men and can worsen with menopause.

Daily dose of PrEP raises coverage, protective drug concentrations

Daily dose of PrEP raises coverage, protective drug concentrations

Recommendations for daily doses of emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF) resulted in protective drug concentrations for men and transgender women.

FDA OKs new medication for individuals with resistant HIV

FDA OKs new medication for individuals with resistant HIV

A new antiretroviral HIV treatment, Trogarzo (ibalizumab-uiyk), has been approved by the FDA for patients with HIV who have not have success with past HIV medications.

Newer HIV testing options underused in Black MSM and transgender women

Newer HIV testing options underused in Black MSM and transgender women

By

Increasing awareness of and access to newer HIV testing options such as free or reduced price on home and self-tests and couples HIV testing and counseling can facilitate increased levels of consistent testing among young, Black MSM, and transgender women.

Bacterial vaginosis may alter links between contraception, HIV acquisition

Bacterial vaginosis may alter links between contraception, HIV acquisition

Bacterial vaginosis may cause an increased risk for HIV acquisition in women taking oral or injectable hormonal contraception.

Alcohol usage not linked to lower short-term CD4 cell count in HIV

Alcohol usage not linked to lower short-term CD4 cell count in HIV

Excessive alcohol consumption does not impact the decline of CD4 cell count in patients with HIV who have not undergone antiretroviral treatments.

HIV care worsened with chronicity of depression

HIV care worsened with chronicity of depression

Chronicity of depression is associated with increased likelihood of failure along the continuum of HIV care.

HIV screening at 25 years optimal for outcomes, cost

HIV screening at 25 years optimal for outcomes, cost

For young adults without known risk factors, a one-time routine HIV screen at 25 years would optimize clinical outcomes and be cost-effective.

Over one-third of U.S. HIV patients are not vaccinated against hepatitis B

One third of HIV patients in the United States remain unvaccinated against hepatitis B.

Combination ART may prevent progressive brain injury in HIV patients

Combination ART may prevent progressive brain injury in HIV patients

Post-seroconversion brain morphology can occur in HIV patients, but aviremia maintenance via cART can slow of prevent brain injuries.

HIV infection to diagnosis time decreasing

HIV infection to diagnosis time decreasing

By

A new report from the CDC finds that HIV is being diagnosed sooner after initial infection than in previous years.

Nivolumab treatment for lung cancer may successfully deplete HIV reservoirs

Nivolumab treatment for lung cancer may successfully deplete HIV reservoirs

Nivolumab treatment for non-small-cell lung cancer may induce successful depletion of HIV reservoir.

HIV occurrences decline in Uganda from 1999 to 2016

HIV occurrences decline in Uganda from 1999 to 2016

The decrease in HIV incidence in Uganda was facilitated by antiretroviral therapy, male circumcision, and adolescent abstinence.

Characteristics in transgender individuals may lead to more HIV tests

Characteristics in transgender individuals may lead to more HIV tests

More tests might be administered to transgender individuals who are female, black, or sex workers.

Dual HIV treatment provides simple, safe salvage regimen

Dual HIV treatment provides simple, safe salvage regimen

The dual combination of dolutegravir plus darunavir/ritonavir provided a simple and safe salvage therapy to suppress viral replication without metabolic impact in patients infected with HIV-1.

Hepatitis increases mortality rates in HIV patients

Hepatitis increases mortality rates in HIV patients

By

Hepatitis B and hepatitis C may increase mortality risks in HIV patients.

Law upheld requiring HIV-infected adults to tell sexual partners of their status

Law upheld requiring HIV-infected adults to tell sexual partners of their status

The Ohio Supreme Court has unanimously upheld the constitutionality of a law requiring HIV-infected individuals to tell their sexual partners of their illness.

CDC updates contraception recommendations for women at risk for HIV

CDC updates contraception recommendations for women at risk for HIV

The CDC revised its US Medical Eligibility Criteria for Contraceptive Use categorization for DMPA injection in women at high risk for HIV infection from US MEC category 1 to US MEC category 2.

Antiretroviral therapy resistance increasing in HIV treatment

Antiretroviral therapy resistance increasing in HIV treatment

Resistance to ART is threatening the recent gains of treatment in the rate of new HIV infections.

High percentage of HIV-diagnosed women not receiving care

High percentage of HIV-diagnosed women not receiving care

More than half of women receiving a new HIV diagnosis have already received this diagnosis in the past but are not undergoing HIV medical care.

HIV care outcomes low for Hispanics and Latinos

HIV care outcomes low for Hispanics and Latinos

Infection was diagnosed at an early stage for fewer males with infection attributed to heterosexual contact vs male-to-male sexual contact.

Single-tablet HIV treatment superior to standard therapy

Single-tablet HIV treatment superior to standard therapy

Virological response, efficacy, noninferiority, and tolerability were tested for bictegravir, emtricitabine, and tenofovir alafenamide in patients with HIV.

Chronic pain management in HIV: Updated recommendations

Chronic pain management in HIV: Updated recommendations

The HIV Medicine Association of the Infectious Disease Society of America recommends that people living with HIV be screened for pain and offered both nonpharmacologic and pharmacologic treatment options.

Notification rates of HIV diagnoses increased in 16 European countries

Notification rates of HIV diagnoses increased in 16 European countries

In 16 countries, notification rates for new HIV diagnoses in older adults increased significantly, clustering in central and eastern European countries.

Once-daily HIV tablet safe for children

Once-daily HIV tablet safe for children

Elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide was well tolerated in children and maintained high virological suppression.

Vitamin D supplements may improve bone health in HIV-infected youth

Vitamin D supplements may improve bone health in HIV-infected youth

By

High-dose vitamin D supplements improve bone mineral density in youth with HIV.

Clinical practice guideline for antiretroviral therapy in pregnant women with HIV

Clinical practice guideline for antiretroviral therapy in pregnant women with HIV

By

Alternative treatments should be offered to pregnant women with HIV instead of tenofovir or emtricitabine.

Smartphone-based electronic reader reliable for point-of-care tests in HIV and <i>T pallidum</i> infections

Smartphone-based electronic reader reliable for point-of-care tests in HIV and T pallidum infections

The findings shed new light on the applicability of smartphone-based electronic readers in point-of-care testing.

Sign Up for Free e-newsletters